Boston, MA · Founded 2018 · Privately Held (backing)
Developer of innovative fibrosis treatment intended for halting and reversing fibrotic activity. Mediar Therapeutics is based in Boston, MA and was founded in 2018. It was valued at $230 million at its later-stage round in Dec 2025, the last priced event on record. It has raised $180 million across 3 recorded rounds; the latest was a $37.8 million early-stage round in Dec 2025.
PMV mark · valuation
$230.0M
Oct 2026
Priced at
its later-stage round
Dec 2025
Total raised
$180.3M
Last round
Early Stage VC
Dec 2025
Cap table — not yet on record
Mediar Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Mediar Therapeutics with a free account
·The complete investor list: 21 names
·Watch Mediar Therapeutics: the Monday email on marks, rounds and moves
Where does Mediar Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Mediar Therapeutics's 3 recorded funding rounds.
